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Objective: To determine, when, how, and which neurons initiate the onset of pathophysiology in amyotrophic lateral
sclerosis (ALS) using a transgenic mutant sod1 zebrafish model and identify neuroprotective drugs.
Methods: Proteinopathies such as ALS involve mutant proteins that misfold and activate the heat shock stress
response (HSR). The HSR is indicative of neuronal stress, and we used a fluorescent hsp70-DsRed reporter in our
transgenic zebrafish to track neuronal stress and to measure functional changes in neurons and muscle over the
course of the disease.
Results: We show that mutant sod1 fish first exhibited the HSR in glycinergic interneurons at 24 hours
postfertilization (hpf). By 96 hpf, we observed a significant reduction in spontaneous glycinergic currents induced in
spinal motor neurons. The loss of inhibition was followed by increased stress in the motor neurons of symptomatic
adults and concurrent morphological changes at the neuromuscular junction (NMJ) indicative of denervation.
Riluzole, the only approved ALS drug and apomorphine, an NRF2 activator, reduced the observed early neuronal
stress response.
Interpretation: The earliest event in the pathophysiology of ALS in the mutant sod1 zebrafish model involves
neuronal stress in inhibitory interneurons, resulting from mutant Sod1 expression. This is followed by a reduction in
inhibitory input to motor neurons. The loss of inhibitory input may contribute to the later development of neuronal
stress in motor neurons and concurrent inability to maintain the NMJ. Riluzole, the approved drug for use in ALS,
modulates neuronal stress in interneurons, indicating a novel mechanism of riluzole action.
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Neurodegenerative diseases including amyotrophiclateral sclerosis (ALS) are characterized by the pres-
ence of protein inclusions in the affected neurons.
Emerging data indicate that protein misfolding may be
of mechanistic importance in these diseases.1 Mutations
in the ubiquitously expressed superoxide dismutase
(SOD1) gene account for 20% of cases of the familial
form of ALS. More than 150 mutations in the SOD1
gene have been discovered, including the point mutations
G93R and G85R.2 Recent studies also implicate SOD1
in the sporadic form of ALS and suggest a prionlike
propagation of misfolded SOD1.3–5 Interestingly, some
of the newly identified genes implicated in ALS, such as
TARDBP and FUS, are also proteins that show a high
propensity to misfold and prionlike activity.6 However,
we still do not know the precise mechanism by which
mutant proteins cause toxicity.5,7 The emerging consen-
sus view is that multiple interacting pathophysiological
factors, including protein misfolding, contribute to the
neuronal toxicity in ALS.8,9
Despite progress in revealing multiple molecular
processes involved in disease pathology, relatively little is
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known about when and how the disekease, which starts
focally, spreads throughout the motor network.10–12
Interestingly, even in the subtypes of ALS caused by
SOD1 mutations, there is considerable phenotypic heter-
ogeneity. Ravits and La Spada12 hypothesized that despite
disease heterogeneity, the disease poses common themes
that may involve common mechanisms. They propose
that ALS may in fact be an orderly, actively propagating
process and that fundamental molecular mechanisms
may be uniform.
The zebrafish is emerging as a useful tool for study-
ing neurological diseases relevant to humans. Previously,
we had shown that mutant sod1 transgenic fish show the
hallmarks of adult onset neurodegenerative ALS, includ-
ing defective motor performance, motor neuron loss, a
loss of neuromuscular connectivity, and muscle atrophy.13
The aforementioned observations demonstrate the useful-
ness of the zebrafish as a model for this disease.
However, among the current limitations when
working with in vivo models of ALS is the lack of a
good readout for the presymptomatic course of the dis-
ease. The zebrafish offer great advantages in studying
early disease processes, as they develop rapidly, reaching
postembryonic life at around 3 days postfertilization
(dpf ), which is developmentally similar to the neonatal
mouse (for a comparison of developmental stages in
human, mouse, and zebrafish, see Table 1). Moreover,
the embryonic and larval zebrafish spinal cord is func-
tionally and anatomically similar to that of humans, yet
it is also optically transparent and experimentally accessi-
ble, making it ideal for the study of spinal circuits in
normal and pathophysiological conditions.14
In the current study, we monitored in vivo early
neurological changes caused by mutant sod1 gene. The
sod1 zebrafish ALS model harbors a fluorescent heat
shock stress response (HSR) reporter gene (hsp70-
DsRed). The HSR is an endogenous cellular pathway
that attempts to refold the damaged proteins in stressed
cells, although this response is not always sufficient or
beneficial.15 Thus, the HSR-mediated DsRed fluores-
cence in the sod1 zebrafish model of ALS represents a
useful tool for monitoring perturbations in cellular ho-
meostasis caused by sod1 mutation. This facilitates the
mapping of disease focality and spread through the cen-
tral nervous system (CNS) by the spatiotemporal readout
of the neuronal stress response in the spinal cord of mu-
tant zebrafish and provides an understanding of the cells
and networks involved in disease propagation in ALS.
We present evidence that the HSR is an indicator
of early pathogenic processes occurring in neurons. The
HSR is first observed at embryonic stages, in discrete
populations of inhibitory interneurons in the spinal cord,
and is followed by dysregulation of glycine release from
these inhibitory interneurons. Furthermore, we observe
that following interneuron dysfunction, motor neurons
start exhibiting neuronal stress. More interestingly, we
show that motor neurons showing the HSR also show
dysfunctional neuromuscular junctions (NMJs). Taken
together, our observations suggest that the mutant sod1-
induced HSR is a robust predictor of neuronal dysfunc-
tion and thus is a reliable marker of disease pathogenesis.
Finally, we also show that the neuronal stress readout can
be used to identify neuroprotective compounds such as
riluzole and identify biological targets that may amelio-
rate early pathophysiological disease processes that are
currently not well explored. Although the sod1 zebrafish
model may by itself not be sufficient in developing new
therapies for ALS, this model system would provide a
rapid way to triage compounds for screening in higher
vertebrate models, with the potential for more rapid
identification of promising compounds for translation
into human clinical trials.
TABLE 1: Comparison of Neural Developmental Stages in Humans, Mice, and Zebrafish
Embryo Fetus
Neural groove Neural tube Spontaneous limb movement Free living
Human 23 dpf 4 wpf 9-10 wpf 40 wpf
Mouse 8.5 dpf 9.5 dpf 12 dpf 21 dpf
Embryo Larvae
Neural thickening Neural keel Spontaneous movement Free living
Zebrafish 10.3 hpf 11.6-16 hpf 17-24 hpf 56-72 hpf
dpf: days post-fertilization; hpf: hours post-fertilization; wpf: weeks post-fertilization; dpp: days post partum. Larval zebrafish:
72hpf-30dpf; juvenile zebrafish: 30 dpf-3months; breeding adult: 3 months-2 years.
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Materials and Methods
Details are given in the Supplementary Materials and Methods.
Generation of Transgenic Zebrafish
The zebrafish sod1 transgenic fish lines were created according
to protocols described previously by Ramesh et al.13 For all the
transgenic strains, a suffix Sh was added (to imply Sheffield
strain). The transgenic lines utilized for this study included the
Tg(sod1:sod1WT;hsp70:DsRed)os4-Sh4, the line expressing the
highest level of WTSod1 (3.3 as compared to nontransgenic
lines), referred to as WTos4-Sh4 line; Tg(sod1:sod1G93R;
hsp70:DsRed)os10-Sh1, referred to as G93Ros10-Sh1 (high ex-
presser with Sod1 expression increased 3 and comparable to
WTos4-Sh4); Tg(sod1:sod1G93R;hsp70:DsRed)os10-Sh2, referred
to as G93Ros6-Sh2 (moderate expresser with Sod1 expression
increased 2.5); and Tg(sod1:sod1G85R; hsp70:DsRed) os6-Sh3
line, referred to as G85Ros6-Sh3 (low expresser with Sod1
expression increased 1.5). When both G93R and G85R lines
are discussed, they are referred to as MUTsod1 lines.
Electrophysiology
Whole cell voltage clamp recordings were conducted in 4 dpf
larvae as previously described.16 The fish were perfused with
Evans physiological saline containing the neuromuscular blocker
D-tubocurarine (10lM), the sodium channel blocker tetrodo-
toxin (TTX; to synaptically isolate neurons), kynurenic acid
(2.5mM, to block spontaneous glutamatergic currents), and
bicuculline (25lM, to block spontaneous c-aminobutyric acid-
ergic [GABAergic] currents). Cells were voltage clamped at
75mV, a potential at which the chloride-conducting glycine
receptors generate inward currents. Sulforhodamine (0.1%) was
included in the electrode solution to visually identify the cell
type. The frequency of glycinergic miniature postsynaptic cur-
rents (mPSCs) was determined by averaging the number of
events in a 300-second period. To examine the rise time, decay,
and amplitude of mPSCs, the first 50 mPSCs were selected
from each recording and averaged across each experimental
condition.
Fluorescent RNA In Situ Hybridization
Fluorescent RNA in situ hybridization was performed on 24
hours postfertilization (hpf) G93Ros10 embryos, as previously
described.17 A mix of equal concentrations of the probes
(glyt2a, glyt2b, and DsRed; gad65,67 and DsRed; or vglut2
and DsRed) was used as previously described.18 Quantification
of cells was done by counting DsRed/glycine-, DsRed/GABA-,
and DsRed/vglut2-positive cells in the midtrunk region, and
the percentage of DsRed cells showing glycine, GABA, or gluta-
mate staining, as well as the percentage of each cell type show-
ing DsRed staining, was calculated from an average of 10
embryos (a total of 429, 505, and 634 DsRed cells were
counted, respectively, for each riboprobe pair).
Immunofluorescence
Immunofluorescence was performed as described by Ramesh
et al.13 Quantitative analysis of confocal images was performed
on image stacks of 16 to 20lm thickness (0.5–1lm/section).
Drug testing
The G93Ros10-Sh4 line was used to identify drugs that inhibit
neuronal stress. Twenty-four hours postfertilization transgenic
embryos (25 embryos/treatment) were incubated with sterile
embryo media with the optimized concentration of the test
compound and changed daily and maintained for 5 days. At 5
dpf, the lysates from transgenic or nontransgenic embryos were
obtained by sonication (Sonicator 4000; Misonix, Farmingdale,
NY) on ice followed by centrifugation. Fifty microliters of su-
pernatant was analyzed in a 96-well plate (Corning-3880;
Corning Life Sciences, Corning, NY) at DsRed wavelength.
Image Analysis
Image analysis for NMJ analysis was performed using National
Institutes of Health ImageJ software, and quantitative analysis
of the NMJ morphology was performed using a colocalization
analysis plugin.19,20
Statistical Analysis
Statistics were performed using Prism 5 (GraphPad Software,
La Jolla, CA). Unpaired t tests or analysis of variance with post
hoc Bonferroni testing were used to compare groups. Electro-
physiological data were compared using the 2-way Kolmo-
gorov–Smirnov test.
Results
Induction of Neuronal Stress in Transgenic
sod1 Zebrafish
When developing the sod1 transgenic zebrafish, we
hypothesized that misfolding of the Sod1 protein in vul-
nerable cell populations would cause cellular stress and
activate the HSR, allowing identification of potentially
dysfunctional neurons. The HSR responsive, hsp70-DsRed
construct that is inserted adjacent to the sod1 gene is
driven by the hsp70 minimal promoter (1.5-kilobase frag-
ment), and is not driven by the adjacent sod1 gene. The
basal hsp70 promoter will allow induction of the DsRed
reporter only in the presence of heat shock or cellular
stress. In the absence of stress or heat shock, the promoter
is silent, and no DsRed is synthesized. This method of re-
porter expression is commonly used in zebrafish research,
and multiple lines within our lab using other transgenes
(eg, SMN) made with this linked expression construct
behave similarly.21
We generated multiple G93R (high expresser:
G93Ros10-Sh1; moderate expresser: G93Ros6-Sh2),
G85R (low expresser: G85Ros6-Sh3), and wild-type (WT;
high expresser: WTos4-Sh4) sod1 transgenic zebrafish car-
rying the hsp70-DsRed stress reporter gene. As expected,
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the sod1 transgenic fish showed red fluorescence through-
out the body and also in the spinal cord upon heat shock
(Fig 1A, þHS). Interestingly, we found that in the absence
of heat shock the embryos expressing Sod1 exhibited spe-
cific DsRed expression in the CNS, indicating the presence
of neuronal stress (see Fig 1A,HS). The high
(G93Ros10-Sh1) and moderate expresser (G93Ros6-Sh2)
mutant sod1 lines showed DsRed induction in distinct
neuronal groups in the dorsal spinal cord. The highest ex-
presser WTos4-Sh4 line showed a minimal level of DsRed
induction, despite having high transgene copy numbers
and 3-fold increased Sod1 protein expression; levels were
identical to the G93Ros10-Sh1 mutant line. Most impor-
tantly, endogenous hsp70 was also upregulated in cells that
expressed DsRed, evident in the neurons that show high
DsRed expression levels. The moderate expresser mutant
and the high expresser WT lines did not show strong
DsRed or detectable hsp70 induction. DsRed is a very sta-
ble protein, and this stability greatly amplifies the hsp70
induction signal. This was shown by a strong DsRed signal
persisting for several days after heat shock (Supplementary
Fig 1E, F) in the transgenic fish, whereas endogenous
hsp70, which is tightly regulated,22 returned to back-
ground levels at 15 hours after heat shock.
Stressed Neurons in the Embryonic Spinal
Cord Are Predominantly Inhibitory
Glycinergic Interneurons
The zebrafish spinal cord is composed of neurons and
glia.23 The neurons include a variety of interneurons and
motor neurons, whereas the glial population consists of
oligodendrocytes that myelinate axons and radial glial cells
(similar to astrocytes) that provide support to neurons.23
To determine the spatiotemporal onset of the HSR in the
spinal cord, we used in situ hybridization and antibody
staining to determine the identity of DsRed-expressing
cells in mutant embryos and larvae. Interestingly, DsRed
expression was never observed in oligodendrocytes, radial
glia, or motor neurons (olig2- or hb9-positive early
FIGURE 1: Sod1 transgenic fish induce the heat shock
response (HSR) without exposure to heat stress. (A) Live
G93Ros10-Sh1 showing induction of hsp70 measured by
DsRed fluorescence at 7 days postfertilization in whole
embryos (top panel) and 30 hours postfertilization (hpf) spinal
cord (bottom panel). Larvae were heat shocked (1HS) or left
unexposed to heat shock (2HS), and images of HSR induction
were compared. When exposed to heat, the larvae showed
global induction of the HSR (left panel), whereas in the ab-
sence of heat shock, only neuronal, neuroepithelial, and occa-
sionally muscle cells show induction of the HSR (right panel).
(B) Multiple mutant lines G93Ros10-Sh1 and G93Ros6-Sh2
show HSR induction in the absence of heat shock. Confocal
images of spinal neurons show induction of endogenous
hsp70 (middle column) in high expresser G93Ros10 line (top
panel) in the same cells that showed strong DsRed expression
(top row, left column). Moderate expresser G93Ros6-Sh2 line
(middle row) and high expresser WTos4-Sh4 line (bottom row)
do not show elevated hsp70 levels above background. (C)
Quantitation of the DsRed fluorescence in individual neurons
in the zebrafish embryonic spinal cord (30 hpf) by average
fluorescence intensity. Average fluorescence of individual
DsRed-positive neurons was measured and analyzed by analy-
sis of variance. *p < 0.05 for G93Ros6-Sh2 and WTos4-Sh4;
***p < 0.0001 for G93Ros10-Sh1 and WTos4-Sh4. Size bars 5
10lM. [Color figure can be viewed in the online issue, which is
available at www.annalsofneurology.org.]
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differentiating and ChAT-positive mature) in the mutant
sod1 larvae (Supplementary Fig 2).
Thus, we reasoned that the first spinal neurons to
activate HSR were likely to be interneurons. We next
sought to determine which interneuron populations ex-
hibit the HSR. The zebrafish spinal cord has been charac-
terized in detail, and the different spinal interneurons have
stereotyped neuroanatomy, with predictable anatomical
positions and axonal trajectories.24 Moreover, each class
expresses 1 of only 3 neurotransmitters: glycine, GABA,
and glutamate.24 We therefore used a combination of ana-
tomical and transmitter expression characteristics to iden-
tify the cell types in which the HSR was present.
To determine whether the stressed neurons of sod1
mutant embryos were glycinergic, we used dual color fluo-
rescence in situ hybridization with riboprobes targeted
against glycine transporter (glyt2a, b) and DsRed RNA. We
observed numerous cells in which glyt2a,b and DsRed
colocalized (Fig 2, top panel). Similarly, DsRed expression
often colocalized with cells positive for antiglycine anti-
bodies (Supplementary Fig 3B). Quantitation of the per-
centage of glycinergic interneurons that showed the neuro-
nal stress response revealed that almost half of the
glycinergic interneurons (49.23 6 12.8 percent) showed
DsRed expression at 24 hpf. The percentage of DsRed-
positive neurons that were glycinergic was 44.2 6 9.5%.
The majority of DsRed-positive cells that coex-
pressed glycine had dorsally located perikarya and axons
that projected rostrally through the dorsolateral aspect of
the spinal cord toward the brain. Such axonal projections
are observed in commissural secondary ascending
(CoSA)–glycinergic (mammalian V0-like), commissural
bifurcating longitudinal (CoBL; mammalian dl6-like),
and circumferential ascending (mammalian V1-like)
interneurons, which comprise the 3 glycinergic interneur-
ons of the zebrafish spinal cord at this stage of
development.24,25
Of these, the CoBL and CoSA interneurons are
pax2 positive.18,25,26 We therefore used anti-pax2 anti-
bodies to label CoBL and CoSA interneurons. However,
as our DsRed and pax2 antibodies were both rabbit
derived, we were limited to monitoring pax2 colocaliza-
tion within strongly DsRed-positive cells unenhanced by
immunolabeling. Multiple fields with interneurons that
showed strong DsRed expression showed colocalization
with pax2 antibody staining (see Supplementary Fig 3A).
To determine whether GABAergic interneurons
expressed the HSR, we performed in situ hybridization
with riboprobes targeted against GABA biosynthetic
enzymes gad65 and gad67. We found that 14.2 6 6.8%
of DsRed-positive neurons had a GABAergic transmitter
phenotype (see Fig 2, middle panel), whereas the per-
centage of GABA-positive neurons that showed HSR was
8.18 6 4.95%.
We next asked whether the HSR occurred in the gluta-
matergic interneurons of the mutant embryonic spinal cord.
Investigation of the expression of the glutamatergic excita-
tory neurotransmitter using vglut2 riboprobes showed that
23 6 5.4% of the DsRed-positive neurons were vglut2
FIGURE 2: Embryonic mutant sod1 zebrafish show induction
of neuronal stress predominantly in the spinal inhibitory glyci-
nergic interneurons. In situ hybridization with probes for inhibi-
tory and excitatory neurons (left panels) and DsRed riboprobes
(middle panel). Top panel: glyt2-positive glycinergic inhibitory
interneurons; middle panel: gad65,67-positive c-aminobutyric
acidergic inhibitory interneurons (dorsal longitudinal ascending
and some glycinergic interneurons); bottom panel: vglut2-posi-
tive excitatory interneurons (commissural primary ascending
and commissural secondary ascending interneurons) that cross-
modulate the spinal locomotor circuitry. Time: 24 hours postfer-
tilization. Size bars 5 10lM. [Color figure can be viewed in the
online issue, which is available at www.annalsofneurology.org.]
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positive (see Fig 2, bottom panel). Analysis of the percentage
of vglut2-positive neurons that showed the HSR indicated
that 10.86 1.94% of vglut2 neurons were DsRed positive.
Glutamatergic interneurons in zebrafish have pri-
mary ascending or descending axons. Among them, the
commissural primary ascending (CoPA) and CoSA-gluta-
matergic interneuronal subtypes have ascending axons.24
After careful examination of >25 DsRed-labeled
embryos, we were unable to see any interneurons with
primary descending axons. Hence, we believe that the
vglut2-positive interneurons that show the HSR are
either CoPA or CoSA-glutamatergic interneurons. Thus,
the populations of neurons that show the HSR in the
embryonic spinal cord were primarily inhibitory glyciner-
gic interneurons, with some GABAergic and glutamater-
gic neurons that modulate the local reciprocal activation
and inhibitory circuits required for swimming.
Reduced Glycinergic Input onto Motor Neurons
following Induction of Interneuron Stress
To this point, our findings suggested that glycinergic
inhibitory interneurons comprise the majority of stressed
neurons in the early mutant sod1 zebrafish spinal cord.
Hence, we used in vivo patch clamp electrophysiology to
monitor glycinergic inputs onto motor neurons at 2 dpf,
a time when the stress response is just manifesting, and
at 4 dpf, a time when the stress response is pervasive.
Glycinergic transmission was monitored during voltage
clamp recordings by synaptically isolating neurons with
the sodium channel blocker TTX and blocking glutamate
and GABA transmission with kynurenic acid (2.5mM)
and bicuculline (25lM), respectively. Under these condi-
tions, spontaneous mPSCs were observed in motor neu-
rons that represented quantal release of glycine from gly-
cinergic interneurons (Fig 3A). The frequency of these
events did not differ significantly in nontransgenic and
WTos4-Sh4 fish (control ¼ 0.68 6 0.09Hz, WTos4-Sh4
¼ 0.84 6 0.13Hz; p > 0.05) but was approximately 50%
lower in motor neurons of sod1 mutant fish (0.32 6
0.05Hz; p < 0.001; see Fig 3A, C). In addition, cumula-
tive probability plots revealed a 15% increase in the half-
life (control ¼ 2.21 6 0.08 milliseconds vs sod1 mutant
¼ 2.55 6 0.08 milliseconds; p < 0.05), but no change in
rise time (control ¼ 0.58 6 0.02 milliseconds vs sod1 mu-
tant ¼ 0.60 6 0.04 milliseconds; p > 0.05) or amplitude
(control ¼ 20.27 6 0.63pA vs sod1 mutant ¼ 18.9 6
0.5pA; p > 0.05) of mPSCs (see Fig 3D). However, at 2
dpf, there were no differences in these parameters between
the WT and mutants (data not shown). Taken together,
these data indicate that the stress response in glycinergic
interneurons is predictive of their impaired function.
Chronic Loss of Inhibitory Input May Contribute
to Motor Neuron Stress
As the motor neurons show dysregulation of inhibitory
input within a few days after birth, potentially due to
pathophysiological changes within inhibitory interneur-
ons, we hypothesized that loss of inhibitory input may
contribute to the onset of motor neuron stress, due to
chronic loss of inhibitory interneuron input.
FIGURE 3: Reduced glycinergic transmission onto motor
neurons of sod1 zebrafish larvae. (A) Representative traces
depicting voltage clamp (holding potential 5 275mV)
recordings of spontaneous glycinergic miniature postsynap-
tic currents (mPSCs) in motor neurons of wild-type (WT), WT
Sod1 overexpresser (WTos4-Sh4), and sod1 mutant
(G93Ros10-Sh1) fish at 4 days postfertilization. Downward
deflections represent occasional quantal release of glycine
from presynaptic terminals. (B) Average of 30 consecutive
glycinergic mPSCs from each experimental condition. (C)
Bar chart depicting mean mPSC frequency for each experi-
mental condition. GlyR 5 glycine receptor; mIPSC 5 minia-
ture inhibitory postsynaptic current. **WT vs G93R p <
0.001. (D) Cumulative probability plots of mPSC amplitude,
rise time, and half-life (p < 0.05) in WT (black lines) and
G93Ros10-Sh1 (gray lines) motor neurons.
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We had earlier shown that staining for pre- and
postsynaptic NMJ markers was reduced in the muscles of
11dpf sod1 transgenic zebrafish.13 However, at these
larval stages NMJs were not grossly perturbed, indicating
that motor neuron loss was unlikely to have occurred at
the stage when DsRed expression is first observed in the
interneuron population.13 Analysis of DsRed expression
in the high expresser G93Ros10-Sh1 line in 9 dpf larvae
(which represent a similar developmental stage to the
preweaning stages in mice) showed widespread stress in
interneurons, but an absence of stress in motor neurons,
suggesting that motor neurons do not show the HSR at
the early larval stage of development (Supplementary Fig
4).
We examined whether symptomatic adult zebrafish,
which were 12 months old, show evidence of motor neu-
ron stress. Interestingly, spinal motor neurons from mu-
tant sod1 adult fish aged 12 to 18 months, which exhibit
reduced motor function, showed evidence of motor neu-
ron stress (Fig 4A, top and middle panels). Greater
DsRed induction in the spinal cord of the high expresser
transgenic line as compared to the low expresser was
observed. However, unlike the 3 independent mutant
sod1 lines, no DsRed expression was observed in the spi-
nal motor neurons of the high expresser WTos4-Sh4 line
(see Fig 4A, bottom panel). This mutant sod1-specific
HSR could also be observed in the motor neurons of
young adult zebrafish at 6 months of age (Supplementary
Fig 5). Thus, it appears that the HSR in motor neurons
is induced between 9 dpf and 6 months of age.
Stressed Motor Neurons Show Reduced
Neuromuscular Synaptic Volume and Loss
of Muscle Innervation
How muscle denervation occurs in ALS is a fundamental
question that remains unanswered, and conflicting data
indicate that both muscle and motor neurons play an im-
portant role in disease pathogenesis.27–29 We had previ-
ously shown that, similar to both mice and humans, the
number of NMJs in the G93Ros10 mutants was
reduced, and the few that remained were abnormally
small and punctate in appearance.13 However, it was
unclear as to whether these perturbations occurred only
at sites innervated by stressed motor neurons. To
FIGURE 4: Mutant sod1 zebrafish show stress in the large spi-
nal motor neurons of the adult spinal cord and concurrent loss
of neuromuscular junction (NMJ). (A) Spinal cord cross sections
from 1- to 1.5-year-old adult zebrafish stained with 40,6-diami-
dino-2-phenylindole (Dapi), DsRed antibody, and ChAT anti-
body show robust induction of the heat shock stress response
in spinal cord motor neurons. DsRed colocalized with ChAT in
the high expresser (33) G93Ros10-Sh1 line (top panel) and the
moderate expresser (32) G85Ros6-Sh3 line (middle panel).
The high expresser (33) WTos4-Sh4 line shows little DsRed
expression, and DsRed did not colocalize with the large ChAT-
positive motor neurons (bottom panel). (B) Muscle sections la-
beled with synaptic vesicle-2 (SV2) antibody (blue), a-
bungarotoxin(a-btx) (green), and DsRed (red) in high expresser
G93Ros10-Sh1 (left panel), low expresser G85Ros6-Sh3 (mid-
dle panel), and high expresser WTos4-Sh4 (right panel). Nor-
mal NMJs are indicated by arrows. Abnormal NMJs
(arrowheads) where pre- and postsynaptic markers are absent
or small and punctate were detected in the muscle sections
from the mutant lines (left and middle panels) but not in the
high expresser wild-type line (right panel). (C) One hundred
thirteen NMJs from multiple sections were measured for NMJ
volume from confocal stacks across multiple planes in SV2-pos-
itive–DsRed-negative axons and SV2-positive–DsRed-positive
axons using colocalization software from National Institutes of
Health Image J and analyzed by unpaired t test. Significant
reduction in NMJ volume was observed associated with
stressed motor axons as compared to the nonstressed axons.
The mean is represented as a line over the distribution. Each
dot represents the volume of an individual NMJ. p < 0.00001.
[Color figure can be viewed in the online issue, which is avail-
able at www.annalsofneurology.org.]
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determine whether this was the case, we compared NMJs
innervated by stressed (DsRed-positive) and nonstressed
(DsRed-negative) motor neurons. DsRed-positive axons
were detected in the musculature of the mutant (see Fig
4B, left and middle DsRed panels) but not in the WT
sod1 transgenic zebrafish (see Fig 4B, right DsRed panel).
We also observed that the DsRed-positive axons in
the high expresser G93Ros10-Sh1 showed no identifiable
NMJ structures and were completely devoid of a-bungar-
otoxin–labeled postsynaptic structures (see Fig 4B, left a-
btx panel). However, in the low expresser G85Ros6-Sh3
muscle sections, we observed that the DsRed-positive
axons showed some recognizable NMJs, which were,
however, abnormally small in size and often punctate in
appearance (see Fig 4B, middle a-btx panel). In contrast,
the nonstressed axons in the same section that did not
show DsRed expression showed large, well-developed
NMJs (see Fig 4B, left and middle a-btx panels).
The high expresser G93Ros10-Sh1 line showed
almost no NMJs arising from the DsRed-expressing
stressed axons, thus limiting quantitative analysis of the
NMJ in this line. Hence, we chose to use the low ex-
presser G85Ros6-Sh3 line for quantitation of NMJ vol-
ume in axons derived from stressed and unstressed neu-
rons. The G85Ros6-Sh3 line showed some NMJ
structures associated with the stressed axons and allowed
appropriate measurement of the effects of stress within
the axonal compartment on NMJ integrity. NMJs were
identified at the distal ends of stressed and nonstressed
axons, and the NMJ volume within the region of interest
was quantitated using 3-dimensional images from confo-
cal stacks.19,20 We observed an almost 5.5-fold decrease
in NMJ volume associated with stressed axons as com-
pared to nonstressed axons (1,097 6 477 vs 6,245 6
864; p < 0.00001; see Fig 4C). The NMJs in the
WTsod1 transgenic line were normal and showed large
and well-developed synapses (see Fig 4B, right a-btx
panel).
Riluzole and NRF2 Activators Reduce
Neuronal Stress
The major impetus for developing the zebrafish ALS
model is their suitability for high-throughput drug
screening, thereby facilitating discovery of drugs that
ameliorate ALS. To determine whether the zebrafish
model has the potential to identify novel ALS therapies,
we tested the ability of the antiexcitotoxic drug riluzole
to modify neuronal stress in zebrafish larvae. Riluzole
was chosen for this study as it is the only drug shown to
have a disease-modifying effect in ALS patients. We sub-
jected 24 hpf G93Ros10-Sh1 embryos to a 4-day incuba-
tion in 1, 3, 5, 7, and 10lM riluzole and used DsRed
fluorescence as a marker for progressive changes in the
neuronal stress response. We observed that riluzole
caused a dose-dependent reduction in DsRed fluores-
cence, with an IC50 of approximately 7lM (Fig 5). Tri-
caine, a local anesthetic that inhibits neuronal sodium
channels30 like riluzole and also reduces excitotoxicity,
produced a significant decrease in DsRed fluorescence
(see Fig 5B).
The NRF2 (nuclear factor [erythroid-derived 2]-
like 2) pathway plays an important role in regulating oxi-
dative stress, the cellular handling of misfolded proteins,
and mounting the autophagy response.31,32 Thus, we
hypothesized that drugs that upregulate this pathway
may potentially reduce neuronal stress in this model sys-
tem. We used R-apomorphine, which is known to be an
activator of the NRF2 antioxidant response (ARE)33 to
determine the effects of ARE induction on the stress
response observed in this model system. Treatment of
FIGURE 5: Inhibition of the stress response in sod1
G93Ros10-Sh1 zebrafish embryos by riluzole and NRF2 acti-
vator R-apomorphine. (A) Dose–response curve showing
dose-dependent inhibition of the stress response by riluzole
in sod1 G93Ros10-Sh1 embryos treated for 4 days with 1,
3, 5, 7, and 10lM riluzole, p < 0.001. (B) Percentage inhibi-
tion of the stress response expressed by reduction in DsRed
fluorescence in embryos treated with 610lM Tricaine (p <
0.000001), 10lM riluzole (p < 0.00001), and 10lM R-apo-
morphine (p < 0.001) as compared to 0.1% dimethyl sulfox-
ide–treated embryos. Mean 6 standard error of the mean.
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embryos with R-apomorphine produced a significant
reduction in the neuronal stress response (see Fig 5B).
Thus, 2 neuroprotective drugs acting through diverse
mechanisms were able to reduce the readout of neuronal
stress in this model system.
Discussion
Zebrafish have become a powerful model for the study
of degenerative diseases, as their experimental accessibil-
ity, small size, and genetic similarity to mammals facili-
tates detailed analysis of disease mechanisms and drug
screens. Zebrafish expressing mutant sod1 develop hall-
mark features of ALS commonly associated with both
murine models and the human disease13 (a comparison
of pathophysiological changes in our sod1 zebrafish
model, SOD1 mouse models, and human ALS is sum-
marized in Table 2).
In the current study, we have extended our analysis
of mutant zebrafish to track early, presymptomatic per-
turbations associated with the Sod1 mutation. Using the
hsp70-DsRed marker gene as a novel readout of neuronal
stress, we have characterized perturbations in the spinal
cord from early embryonic stages through to adult life,
establishing a correlation between neuronal stress and
pathophysiological changes in stressed neurons. We find
that in early stages of development, inhibitory neurons
are sensitive to the presence of mutant Sod1, activating
the stress response upon its expression. Moreover, using
electrophysiological approaches, we show that glycinergic
neurotransmission onto motor neurons is impaired in
mutant sod1 fish. These perturbations precede the onset
of pathophysiological defects in the motor neurons and
at the neuromuscular junction, which occur later in life.
SOD1 is a ubiquitously expressed protein, but
mutation in the SOD1 gene produces a disease affecting
the CNS. How this gene selectively perturbs neurons
during ALS is not well understood, although the
accepted view is that neurons are selectively sensitive to
mutant SOD1. Our observation suggests that neuronal
stress as measured by the HSR response occurs in spinal
interneurons long before it is observed in motor neurons.
This implicates interneurons as important components of
ALS disease progression in this mutant sod1 zebrafish
model. More importantly, we provide for the first time
evidence that this process occurs in vivo.
A possible role for inhibitory interneurons in ALS
has been hypothesized previously (see Turner and
Kiernan34 for a comprehensive review on this subject).
Both human ALS patients and mouse SOD1 models
have been reported to show a loss of spinal cord
TABLE 2: Summary of ALS Disease Pathophysiology in Humans, Mice, and Zebrafish
Neuronal
stress
Electro-
physiology
NMJ
denervation
Cellular
changes,
insoluble
aggregates
Astrocytosis/
Microgliosis/
Mitochondria/
Inclusion/UPS
Gross motor
symptoms
Human ? Prior to
onset
in adults†
Prior to
onset in
adults†
Golgi, mitochondria,
insoluble aggregates
In post-mortem
specimens
In post-mortem
specimens
40-50 years
Mouse
(Sod1G93
AHiGur)
? 12 dpf* to
6 dpp**
(G85R,
G93Alow)
~30dpp Golgi changes
~40-50dpp
~70-90dpp ~100dpp
Zebrafish
(G93R)
24 hpf **
(This
manuscript)
96hpf**
(This
manuscript)
Normal NMJ
but reduced
staining at 11dpf.
6 months and 1
year Observed
denervation in
stressed motor
neuron (This
manuscript)
UPR at 1
month***.
No gross
inflammation
(unpublished)
Motor neuron
stress. 6-months
(This manuscript)
1 year
dpf: days post fertilization; hpf: hours post fertilization; dpp: days postpartum. UPR: Unfolded Protein Response †earliest tested, *
earliest tested in organotypic culture; ** Earliest tested in intact spinal cord, *** Personal communication (C.Beattie)
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interneurons, aberrant recurrent inhibition, and motor
neuron hyperexcitability, observations that suggest that
dysregulation of inhibitory influences on motor neurons
may represent an early aspect of disease pathophysiol-
ogy.11,35–38 Moreover, recent in vitro studies show that
motor neurons derived from SOD1 mice have abnormal
glycine receptor expression and reduced responses to gly-
cinergic input.39 As shown in Table 2, electrophysiologi-
cal abnormalities are the earliest changes observed in
mice, suggesting that early pre- and postnatal develop-
ment is an area important for investigation in relation to
the mechanisms of SOD1 toxicity. Together, these obser-
vations suggest that defective inhibitory transmission may
promote motor neuron stress and accelerate disease pro-
gression. It is perhaps worth noting that that human
patients carrying the SOD1D90A homozygous mutations
develop an atypical slowly progressing form of ALS, and
in these patients, inhibitory interneurons are spared.40
However, Hossaini et al41 reported that interneuron pa-
thology occurred following motor neuron death in the
low expresser SOD1G93A mice. This study was limited
to examining adult mice, a few weeks prior to the onset
of symptoms, and did not look at early embryonic or
neonatal animals. Interestingly, mice from this line show
evidence of hyperexcitability as early as postnatal day 6
to 10, long before the onset of symptoms.42 The source
of this hyperexcitability is still unclear, but the data pre-
sented in this paper raise the possibility that dysfunc-
tional inhibitory interneurons may be responsible for
these changes. Future studies looking at different neuro-
nal populations during embryonic, neonatal, and adult
stages of development in the mutant SOD1 mouse model
would be necessary to establish the exact timing of dam-
age to various cell types.
Interestingly, overexpression of WT Sod1 also
induced neuronal stress in interneurons, albeit at a much
lower level than in the mutant sod1 zebrafish lines. This
observation stands in agreement with previous studies
that show high levels of WT SOD1 are toxic, although
to a much lesser extent than mutant SOD1.3,5,43 For
example, transgenic mice that overexpress WT SOD1
also show motor neuron loss, although it occurs far later
(2 years).44 It is important to note that the high expresser
G93Ros10 line that expresses similar levels of Sod1 to
the WTos4 line showed a 10-fold greater HSR induction
compared to the WT-expressing line. Similar to the
mouse overexpressing WTSOD1 where the disease was
limited and not progressive, in WTSod1-overexpressing
transgenic zebrafish, the HSR failed to spread to motor
neurons, to produce NMJ denervation, or to cause mus-
cle atrophy. Our observations are in keeping with those
seen in WTSOD1-overexpressing transgenic mice.
Another interesting finding from our study is that motor
neurons did not show induction of the HSR at the early
embryonic and larval stages, a time when inhibitory
interneurons exhibited clear dysfunction. Rather, the
onset of HSR induction in motor neurons occurred long
after, as the fish progressed toward adult life. These find-
ings suggest that the pathophysiological changes are not
static but spread progressively through the neural net-
work controlling motor system function. The findings in
this zebrafish model indicate that inhibitory interneurons
may be the cell type within the spinal cord most suscep-
tible to neuronal stress induced by the presence of mu-
tant Sod1. One route for the propagation of the patho-
physiology from inhibitory interneurons to motor
neurons is through dysregulation of the inhibitory input
to motor neurons, as discussed earlier. The zebrafish
model we have generated offers new approaches to test
this hypothesis and identify the circuitry involved in the
pathophysiological cascade.
Dying back axonal pathology is among the pro-
posed mechanisms leading to motor neuron death,
although we do not know whether this occurs as a pri-
mary event or secondary to changes in the motor neuron
perikaryon.45,46 We had earlier shown that NMJs in mu-
tant sod1 transgenic strains were reduced, and the few
that were present were morphologically abnormal (small
and punctate). This HSR readout in our zebrafish model
allows us to track the axons of stressed motor neurons
into the muscle and evaluate whether stress in the motor
neuron perikaryon leads to detectable pathology at the
NMJ. We show that NMJs from stressed motor neurons
were abnormal, as they were absent or were small and
punctate in appearance as compared to nonstressed
axons. This effect was specific to the mutant Sod1 lines
and was not observed in the WT Sod1 overexpressing
line. This indicates that the stress we observe in the
motor neuron perikarya is predictive of synaptic degener-
ation at the NMJ. The sod1 zebrafish model will allow
more detailed dissection of the processes involved in de-
nervation at the NMJ, as now we can distinguish motor
axons arising from nonstressed and stressed motor
neurons.
Based on the combination of novel findings in the
sod1 zebrafish model of ALS, we propose a draft model
of ALS disease propagation in which neuronal stress
begins very early in life, initially affecting the inhibitory
interneuron pool, whose dysfunction may then contrib-
ute to pathophysiological changes in motor neurons later
in life (Fig 6B). In this proposed model, it is also possi-
ble that interneurons are more vulnerable to the toxic
effects of mutant Sod1, whereas motor neurons may
require 2 hits (Sod1 toxicity and loss of inhibition) to
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drive pathology. Future cell-specific transgene expression
and/or tissue transplant studies, which can be performed
in zebrafish embryos, will allow further exploration of
this hypothesis. Nonetheless, stressed motor neurons are
unable to maintain normal NMJs, which may in turn
lead to lack of the trophic support necessary for mainte-
nance of functional neuromuscular contacts, thereby
leading to denervation. Such a model has been previously
suggested,46 but here we propose that stressed motor
neurons are dysfunctional and induce a dying back phe-
notype, whereas NMJs of nonstressed neurons remain
intact. The evidence we provide here shows a direct link
between the level of chronic neuronal stress and neuro-
muscular degeneration.
Although we note that the early disease features
seen in this zebrafish model (electrophysiological changes
and NMJ denervation) are also observed in the presymp-
tomatic rodent models of SOD1-related ALS and to a
limited extent in presymptomatic human patients, further
work is necessary to determine whether these early
changes reflect the initiation of a progressive pathophys-
iological cascade that eventually culminates in motor
neuron loss. However, the similarities in the pathophysio-
logical changes occurring across these diverse species and
the gradual nature of these changes that precede motor
neuron loss suggest that they are likely to represent an
integral component of the disease process. Nevertheless,
the ability to use zebrafish to monitor these changes in
real time in vivo due to their small size, transparency,
and easy accessibility provides us with a valuable tool for
studying the cascade of motor neuron injury in ALS
from early pathophysiological changes to motor neuron
cell death.
The sod1 zebrafish model also holds promise as a
link between cell-based assays and rodent models, thus
providing a new platform for high-throughput screening
of neuroprotective compounds. In the current study, we
tested the effects of riluzole, the only therapeutic com-
pound that has shown benefit in both the SOD1G93A
murine models and human ALS patients, on neuronal
stress in the mutant sod1 zebrafish larvae. We found
that riluzole reduced the HSR in zebrafish, indicating
that it may slow progression of disease. Although rilu-
zole shows efficacy in ALS, the mechanism by which it
mediates neuroprotection is still unclear. Riluzole is
known to reduce neuronal excitability by stabilizing the
inactive state of voltage-gated sodium channels and also
by acting as a noncompetitive N-methyl-D-aspartate re-
ceptor antagonist.47 Interestingly, Tricaine, another drug
that modulates voltage-gated sodium channels, showed
a similar inhibition of the HSR. Together, these obser-
vations suggest that modulation of neuronal sodium
channel activation may affect disease progression, possi-
bly in an activity-dependent manner. Dissecting the
molecular mechanisms by which riluzole reduces the
neuronal stress response will be useful and may allow
the development of compounds with greater neuropro-
tective efficacy. We also identified that activators of the
NRF2 transcription factor, which plays an important
role in neuroprotection and operates as a master regula-
tor of the antioxidant and stress response pathways, can
also modulate the early neuronal stress response
observed in this model. Although this early stage
screening allowed identification of neuroprotective com-
pounds, further validation of hits from this assay will
be necessary in higher vertebrate models of ALS. The
in vivo high throughput zebrafish model fills an impor-
tant gap in ALS drug discovery and may provide lead
candidates for drug screening in rodent models, thus
accelerating the drug discovery process in ALS with the
potential for more rapid identification of promising
compounds for clinical translation.
FIGURE 6: Model of neuronal stress propagation in zebra-
fish model of amyotrophic lateral sclerosis. (A) Although
wild-type (WT) Sod1 overexpresser zebrafish show some
interneuron stress in early development, the stress levels
are low and there is no propagation of the stress response
to motor neurons. (B) Mutant sod1 transgenic zebrafish
show stress initially in the inhibitory interneurons that cause
dysfunction of glycinergic inhibitory interneurons with
reduced glycinergic input to motor neurons. This lack of in-
hibition may be a factor contributing to the stress response
developing in motor neurons in the adult zebrafish.
Stressed motor neurons are unable to maintain synaptic
function with resulting synaptic withdrawal at the neuro-
muscular junction (NMJ). The retraction of the presynaptic
input at the NMJ may lead to a loss of trophic support
from muscle, resulting in a vicious cycle of injury to the
motor neuron, eventually leading to motor neuron degener-
ation and muscle atrophy. Shades of gray indicate stress
levels.
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